USPTO serial 77076482
LIQUID CRYSTAL PHARMACEUTICALS
Reviewed by CopyMark Law Group
Reg. 3463124Status 710
- Filing date
- Status date
- Registration date
- Jul 8, 2008
- Examiner
- CASTRO, GIANCARLO
- Law office
- TMO LAW OFFICE 110
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LIQUID CRYSTAL PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
El Cajon, CA
El Cajon, CA
El Cajon, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alfred J. Mangels
Alfred J. Mangels Alfred J. Mangels4729 Cornell RoadCincinnati, OH 45241UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-cancer preparations; anti-diabetic pharmaceuticals; antibacterial pharmaceuticals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations namely, anticoagulants; pharmaceutical preparations namely,antidepressants; pharmaceutical preparations namely,appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, lipid lowering agents; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; synthetic peptides for pharmaceutical purposes | SECTION 8 - CANCELLED | Feb 28, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 15, 2019 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 8, 2017 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jul 24, 2013 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 24, 2013 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 24, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 10, 2013 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 8, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 2, 2008 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| May 31, 2008 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 5, 2008 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 14, 2008 | IUAF | USE AMENDMENT FILED | — |
| Mar 14, 2008 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 13, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 21, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| May 14, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 14, 2007 | ALIE | ASSIGNED TO LIE | — |
| Apr 26, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 26, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 25, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2007 | NWAP | NEW APPLICATION ENTERED | — |